Date: 02-07-2016
0716 E015
Second Year MBBS Examination
II MBBS Pharmacology Paper 1
Time: 2 hours Max Marks: 40
1. Answer to the points.
2. Figure to the right indicates marks.
3. Use separate answer books for each
section.
5. Write legibly.
Section 1
1. Write briefly (any two)
(10)
of dyslipidemia. Describe the
mechanism of action, therapeutic uses
and adverse effects of atorvastatin.
(A.635, 637)
mechanism of action, therapeutic uses
and adverse effects of lignocaine. (A.
363, B. 241)
c) Classify ACE inhibitors. Describe
and adverse effects of enalapril. (A.
501, B. 422)
2. Write briefly (any three)
(12)
386, . 105)
b) Compare and contrast atenolol and
metoprolol(A. 145, 563, B. 272)
c) Drug treatment of
. 289)
d) Pharmacological factors affecting
bioavailability. (A. 16, . 11,12)
3. Write briefly (any three)
a) Leukotriene antagonists(A. 228, .
360)
b) Compare and contrast ibuprofen
and etoricoxib (A.206)
d) Mivacurium (A. 354)
4. Answer in one or two
sentences (any six):
(6)
of levodopa and carbidopa in
parkinsonism
b) Pharmacological basis for the use
of aspirin and clopidogrel in ischemic
c) Pharmacological basis for the use
of ipratromium bromide in COPD
patients
d) Pharmacological basis for the use
patients with ascites and edema (A.
559, 579)
e) Pharmacological basis for the use
of pilocarpine in acute congestive
f) Pharmacological basis for the use of
tamsulocin in benign hypertrophy of
prostate
g) Pharmacological basis for the use
h) Pharmacological basis for the use
of nitrates and calcium channel
blockers in angina patients
0716 E015
Second Year MBBS Examination
II MBBS Pharmacology Paper 1
Time: 2 hours Max Marks: 40
--- Content provided by FirstRanker.com ---
Instructions:1. Answer to the points.
2. Figure to the right indicates marks.
3. Use separate answer books for each
section.
--- Content provided by FirstRanker.com ---
4. Draw diagrams wherever necessary.5. Write legibly.
Section 1
1. Write briefly (any two)
(10)
--- Content provided by FirstRanker.com ---
a) Classify drugs used in the treatmentof dyslipidemia. Describe the
mechanism of action, therapeutic uses
and adverse effects of atorvastatin.
(A.635, 637)
--- Content provided by FirstRanker.com ---
b) Classify local anesthetics. Describemechanism of action, therapeutic uses
and adverse effects of lignocaine. (A.
363, B. 241)
c) Classify ACE inhibitors. Describe
--- Content provided by FirstRanker.com ---
mechanism of action, therapeutic usesand adverse effects of enalapril. (A.
501, B. 422)
2. Write briefly (any three)
(12)
--- Content provided by FirstRanker.com ---
a) Preanesthetic medication (A. 118,386, . 105)
b) Compare and contrast atenolol and
metoprolol(A. 145, 563, B. 272)
c) Drug treatment of
--- Content provided by FirstRanker.com ---
organophosphorous poisoning(A. 110,. 289)
d) Pharmacological factors affecting
bioavailability. (A. 16, . 11,12)
3. Write briefly (any three)
--- Content provided by FirstRanker.com ---
(12)a) Leukotriene antagonists(A. 228, .
360)
b) Compare and contrast ibuprofen
and etoricoxib (A.206)
--- Content provided by FirstRanker.com ---
c) Sodium valproate(A. 417, B. 131)d) Mivacurium (A. 354)
4. Answer in one or two
sentences (any six):
(6)
--- Content provided by FirstRanker.com ---
a) Pharmacological basis for the useof levodopa and carbidopa in
parkinsonism
b) Pharmacological basis for the use
of aspirin and clopidogrel in ischemic
--- Content provided by FirstRanker.com ---
heart diseasec) Pharmacological basis for the use
of ipratromium bromide in COPD
patients
d) Pharmacological basis for the use
--- Content provided by FirstRanker.com ---
of furosemide and spironolactone inpatients with ascites and edema (A.
559, 579)
e) Pharmacological basis for the use
of pilocarpine in acute congestive
--- Content provided by FirstRanker.com ---
glaucoma. (A.155, B. 1028)f) Pharmacological basis for the use of
tamsulocin in benign hypertrophy of
prostate
g) Pharmacological basis for the use
--- Content provided by FirstRanker.com ---
of zolpidem in sleep onset insomniah) Pharmacological basis for the use
of nitrates and calcium channel
blockers in angina patients